
Nancy Bitar
Examiner (ID: 18935, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1257 |
| Issued Applications | 1017 |
| Pending Applications | 63 |
| Abandoned Applications | 197 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7651795
[patent_doc_number] => 20110301064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'SIGNAL SEQUENCE-INDEPENDENT PIX PHAGE DISPLAY'
[patent_app_type] => utility
[patent_app_number] => 13/201334
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9583
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301064.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201334 | Signal sequence-independent pIX phage display | Feb 23, 2010 | Issued |
Array
(
[id] => 9454924
[patent_doc_number] => 08715928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Molecular-based method of cancer diagnosis and prognosis'
[patent_app_type] => utility
[patent_app_number] => 13/148851
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 27410
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148851
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148851 | Molecular-based method of cancer diagnosis and prognosis | Feb 11, 2010 | Issued |
Array
(
[id] => 7755597
[patent_doc_number] => 20120028278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'CELL LINES EXPRESSING GUANYLATE CYCLASE-C AND METHODS OF USING THEM'
[patent_app_type] => utility
[patent_app_number] => 13/147325
[patent_app_country] => US
[patent_app_date] => 2010-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17227
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028278.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147325 | CELL LINES EXPRESSING GUANYLATE CYCLASE-C AND METHODS OF USING THEM | Jan 31, 2010 | Abandoned |
Array
(
[id] => 6350853
[patent_doc_number] => 20100331204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'METHODS AND SYSTEMS FOR ENRICHMENT OF TARGET GENOMIC SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 12/695447
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14578
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331204.pdf
[firstpage_image] =>[orig_patent_app_number] => 12695447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695447 | METHODS AND SYSTEMS FOR ENRICHMENT OF TARGET GENOMIC SEQUENCES | Jan 27, 2010 | Abandoned |
Array
(
[id] => 6320408
[patent_doc_number] => 20100196357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Microrna modulators and method for identifying and using the same'
[patent_app_type] => utility
[patent_app_number] => 12/691448
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14448
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12691448
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/691448 | Microrna modulators and method for identifying and using the same | Jan 20, 2010 | Abandoned |
Array
(
[id] => 10609143
[patent_doc_number] => 09329170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-03
[patent_title] => 'Single cell gene expression for diagnosis, prognosis and identification of drug targets'
[patent_app_type] => utility
[patent_app_number] => 12/657457
[patent_app_country] => US
[patent_app_date] => 2010-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22971
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12657457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657457 | Single cell gene expression for diagnosis, prognosis and identification of drug targets | Jan 19, 2010 | Issued |
Array
(
[id] => 6616329
[patent_doc_number] => 20100310601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Adeno-Associated Virus Materials and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/689610
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7051
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310601.pdf
[firstpage_image] =>[orig_patent_app_number] => 12689610
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/689610 | Adeno-Associated Virus Materials and Methods | Jan 18, 2010 | Abandoned |
Array
(
[id] => 6437762
[patent_doc_number] => 20100144029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Facilitating Protein Solubility by Use of Peptide Extensions'
[patent_app_type] => utility
[patent_app_number] => 12/684195
[patent_app_country] => US
[patent_app_date] => 2010-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9843
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12684195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/684195 | Facilitating protein solubility by use of peptide extensions | Jan 7, 2010 | Issued |
Array
(
[id] => 10897837
[patent_doc_number] => 08921051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Methods and means for typing a sample comprising colorectal cancer cells'
[patent_app_type] => utility
[patent_app_number] => 13/141742
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10532
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141742 | Methods and means for typing a sample comprising colorectal cancer cells | Dec 22, 2009 | Issued |
Array
(
[id] => 7656821
[patent_doc_number] => 20110306090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Mammalian Expression Vector'
[patent_app_type] => utility
[patent_app_number] => 13/141005
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8291
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306090.pdf
[firstpage_image] =>[orig_patent_app_number] => 13141005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141005 | Mammalian expression vector | Dec 17, 2009 | Issued |
Array
(
[id] => 9950863
[patent_doc_number] => 08999647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Methods of subclassification of ductal carcinoma in situ of the breast'
[patent_app_type] => utility
[patent_app_number] => 13/255558
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4165
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255558 | Methods of subclassification of ductal carcinoma in situ of the breast | Dec 10, 2009 | Issued |
Array
(
[id] => 8066157
[patent_doc_number] => 20110243939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS'
[patent_app_type] => utility
[patent_app_number] => 13/139185
[patent_app_country] => US
[patent_app_date] => 2009-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14627
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243939.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139185
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139185 | MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS | Dec 10, 2009 | Abandoned |
Array
(
[id] => 11923877
[patent_doc_number] => 09791452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Methods of diagnosing and predicting renal disease'
[patent_app_type] => utility
[patent_app_number] => 13/130711
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 10421
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13130711
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130711 | Methods of diagnosing and predicting renal disease | Dec 8, 2009 | Issued |
Array
(
[id] => 11305096
[patent_doc_number] => 09512484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Methods for determining a prognosis for survival for a patient with breast cancer'
[patent_app_type] => utility
[patent_app_number] => 13/145859
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3567
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145859
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145859 | Methods for determining a prognosis for survival for a patient with breast cancer | Dec 7, 2009 | Issued |
Array
(
[id] => 6374923
[patent_doc_number] => 20100081200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'FORMULATIONS AND METHODS FOR CULTURING STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/632057
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13095
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12632057
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632057 | FORMULATIONS AND METHODS FOR CULTURING STEM CELLS | Dec 6, 2009 | Abandoned |
Array
(
[id] => 7651786
[patent_doc_number] => 20110301055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'METHODS FOR DETERMINING A PROGNOSIS IN MULTIPLE MYELOMA'
[patent_app_type] => utility
[patent_app_number] => 13/132422
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12546
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301055.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132422
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132422 | METHODS FOR DETERMINING A PROGNOSIS IN MULTIPLE MYELOMA | Dec 3, 2009 | Abandoned |
Array
(
[id] => 7710994
[patent_doc_number] => 20120003655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'IDENTIFICATION OF NEUROPROTECTIVE AGENTS USING PRO-INFLAMMATORY HUMAN GLIAL CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/132260
[patent_app_country] => US
[patent_app_date] => 2009-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 21917
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132260
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132260 | IDENTIFICATION OF NEUROPROTECTIVE AGENTS USING PRO-INFLAMMATORY HUMAN GLIAL CELLS | Dec 2, 2009 | Abandoned |
Array
(
[id] => 8642419
[patent_doc_number] => 08367402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Extranuclear RNA splicing in neuronal dendrites'
[patent_app_type] => utility
[patent_app_number] => 12/628860
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 83
[patent_no_of_words] => 15842
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12628860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/628860 | Extranuclear RNA splicing in neuronal dendrites | Nov 30, 2009 | Issued |
Array
(
[id] => 8209909
[patent_doc_number] => 20120129167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'TRUNCATED CD20 PROTEIN, DELTACD20'
[patent_app_type] => utility
[patent_app_number] => 13/129509
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7134
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129167.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129509
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129509 | Truncated CD20 protein, deltaCD20 | Nov 16, 2009 | Issued |
Array
(
[id] => 7696218
[patent_doc_number] => 20110230372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'GENE EXPRESSION CLASSIFIERS FOR RELAPSE FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE IMPROVE RISK CLASSIFICATION AND OUTCOME PREDICTION IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/998474
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 56411
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230372.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998474 | GENE EXPRESSION CLASSIFIERS FOR RELAPSE FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE IMPROVE RISK CLASSIFICATION AND OUTCOME PREDICTION IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA | Nov 15, 2009 | Abandoned |